edp-235
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 28, 2022 (NCT05246878)
Timeline
Indications
Studied for
Mechanism of action
- Caspase-8ANTAGONIST
CASP8 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05616728 | Phase 2 | Nov 10, 2022 | Enanta Pharmaceuticals |
| NCT05594602 | Phase 1 | Oct 31, 2022 | Enanta Pharmaceuticals |
| NCT05594615 | Phase 1 | Oct 6, 2022 | Enanta Pharmaceuticals |
| NCT05246878 | Phase 1 | Jan 28, 2022 | Enanta Pharmaceuticals |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Enanta Pharmaceuticals | For profit | 4 | 4 | 2 | 2022 |
1 organizations
Page 1 / 1